Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bivona

Showing results (51-60 of 514) with videos related to

Pageof 52
Sort By:
Molecular Cell|December 8, 2023
Unlocking the EGFR-mediated epitranscriptome: A pathway to novel therapiesJovanka Gencel-Augusto, Trever G Bivona
International Journal of Molecular Sciences|December 9, 2023
Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?Giulia Bivona, Matilda Iemmolo, Giulio Ghersi
Current Opinion in Cell Biology|March 22, 2003
Ras pathway signaling on endomembranesTrever G Bivona, Mark R Philips
Trends in Molecular Medicine|January 29, 2019
Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer BiologyAmit J Sabnis, Trever G Bivona
Journal of Thoracic Disease|May 1, 2018
The evolving understanding of immunoediting and the clinical impact of immune escapeCaroline E McCoach, Trever G Bivona
Annals of Clinical and Laboratory Science|August 13, 2017
Vitamin D and Immunomodulation: Is It Time to Change the Reference Values?Giulia Bivona, Luisa Agnello, Marcello Ciaccio
Cell Cycle (Georgetown, Tex.)|October 1, 2016
HSP70 dependence in rhabdomyosarcoma: Seed or soil?Amit J Sabnis, Trever G Bivona
Lung Cancer (Auckland, N.Z.)|February 18, 2017
AXL receptor tyrosine kinase as a therapeutic target in NSCLCRoss A Okimoto, Trever G Bivona
Cancer Discovery|October 17, 2012
Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistanceCollin M Blakely, Trever G Bivona
Optics Express|June 18, 2009
Photodetachment of F(-) by a few-cycle circularly polarized laser fieldSaverio Bivona, Riccardo Burlon, Claudio Leone
Pageof 52

Showing results (51-60 of 514) with videos related to

Sort By:
Pageof 52
Molecular Cell|December 8, 2023
Unlocking the EGFR-mediated epitranscriptome: A pathway to novel therapiesJovanka Gencel-Augusto, Trever G Bivona
International Journal of Molecular Sciences|December 9, 2023
Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?Giulia Bivona, Matilda Iemmolo, Giulio Ghersi
Current Opinion in Cell Biology|March 22, 2003
Ras pathway signaling on endomembranesTrever G Bivona, Mark R Philips
Trends in Molecular Medicine|January 29, 2019
Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer BiologyAmit J Sabnis, Trever G Bivona
Journal of Thoracic Disease|May 1, 2018
The evolving understanding of immunoediting and the clinical impact of immune escapeCaroline E McCoach, Trever G Bivona
Annals of Clinical and Laboratory Science|August 13, 2017
Vitamin D and Immunomodulation: Is It Time to Change the Reference Values?Giulia Bivona, Luisa Agnello, Marcello Ciaccio
Cell Cycle (Georgetown, Tex.)|October 1, 2016
HSP70 dependence in rhabdomyosarcoma: Seed or soil?Amit J Sabnis, Trever G Bivona
Lung Cancer (Auckland, N.Z.)|February 18, 2017
AXL receptor tyrosine kinase as a therapeutic target in NSCLCRoss A Okimoto, Trever G Bivona
Cancer Discovery|October 17, 2012
Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistanceCollin M Blakely, Trever G Bivona
Optics Express|June 18, 2009
Photodetachment of F(-) by a few-cycle circularly polarized laser fieldSaverio Bivona, Riccardo Burlon, Claudio Leone
Pageof 52